English 
株式会社Ubieは、亀田総合病院と共同で、AIパートナーを活用した新たな肥満治療モデルの実証実験を2025年11月より開始したことをお知らせいたします。.
Obesity is not simply weight gain; it is a disease that can lead to health problems such as high blood pressure and diabetes, and requires specialized treatment. However, in Japan, many patients hesitate to seek medical treatment due to social prejudice that it is a “personal responsibility issue,” and even after treatment begins, it can be difficult to continue diet and exercise regimens.(*) Furthermore, even in busy medical settings, there are limits to the amount of ongoing support that delves into the lifestyle habits of each patient, and a new approach is needed. This AI partner initiative combines Ubie’s AI technology with Kameda General Hospital’s top-class clinical expertise in Japan.
Under this new treatment model, obesity patients at Kameda General Hospital will utilize a conversational AI partner developed by Ubie. The AI Partner is a service that supports the health of each patient through dialogue with AI. It provides an environment where patients can consult 24 hours a day about topics that cannot be discussed within the limited time of outpatient treatment, such as diet, exercise, and concerns about treatment. By providing information from a medical perspective based on treatment guidelines and empathizing with patients’ emotions, it supports positive behavioral change and treatment continuity. Ubie’s preliminary testing has already received multiple positive comments, including that the information provided by the AI Partner has led to actual behavioral change and anxiety relief.
こちらもお読みください： LEQEMBI皮下注製剤の日本における製造販売承認申請について
ウビー そして 亀田総合病院 は、この取り組みを通じて得られた患者の行動変容に関するデータを蓄積・分析し、より良い支援に役立てていきます。将来的には、医療従事者の働き方改革の推進や病院経営課題の解決に貢献することを目指します。.
ソース PRタイムズ
日本語